Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV002247236 | SCV002520048 | likely pathogenic | not provided | 2021-09-14 | criteria provided, single submitter | clinical testing | PM2, PM3_supporting, PVS1_strong |
Baylor Genetics | RCV000002082 | SCV004201060 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2022-12-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002247236 | SCV005437445 | likely pathogenic | not provided | 2024-06-12 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in abnormal protein length as the last 24 amino acids are replaced with 49 different amino acids, and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 8923014) |
OMIM | RCV000002082 | SCV000022240 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 1996-11-01 | no assertion criteria provided | literature only |